Core Laboratories (CLB) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Core Laboratories (CLB) PT Raised to $26 at Cowen
July 24, 2020 8:06 AM EDTCowen analyst Marc Bianchi raised the price target on Core Laboratories (NYSE: CLB) to $26.00 (from $24.00) while maintaining a Market Perform rating.
... MoreCore Laboratories (CLB) PT Raised to $27 at RBC Capital
July 23, 2020 1:58 PM EDTRBC Capital analyst Kurt Hallead raised the price target on Core Laboratories (NYSE: CLB) to $27.00 (from $24.00) while maintaining an Outperform rating.
The analyst commented, "CLB continues to adhere to its long standing financial tenets of maximizing FCF, ROIC and returning excess... More
